内科学
医学
内分泌学
锌
脂肪变性
脂肪肝
肝病
疾病
巨噬细胞
生物
糖尿病
新陈代谢
病理生理学
慢性肝病
缺锌(植物性疾病)
发病机制
血甘油三酯
非酒精性脂肪肝
免疫学
肝脏代谢
免疫病理学
病理
作者
Jiahui Zhou,Xinhui Wang,Wen‐Yue Liu,Yingying Yu,Shujie Wang,Ziqin Yao,Zijun Song,Wanting Shi,Wanru Zheng,Enjun Xie,Yi Yang,Shumin Sun,Xiaotian Wu,Pinanong Na-Phatthalung,Li‐You Lian,Junxia Min,Fudi Wang
标识
DOI:10.1038/s41392-026-02816-z
摘要
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 1 billion people globally, yet the role of trace elements in its progression remains poorly defined. Here, we identify "macrophage zinc trapping" (i.e., selective zinc accumulation in hepatic macrophages despite systemic zinc depletion) as a critical driver of MASLD. In a cohort of 1069 individuals with MASLD, we found that serum zinc levels were inversely correlated with the disease severity. In a mouse model of MASLD, the hepatic macrophages are marked by zinc accumulation. Macrophage-specific depletion of the zinc exporter Slc30a1 in mice recapitulates human MASLD pathology. In macrophage-specific Slc30a1-deficient mice, trapped zinc activates the Ire1α-Xbp1s pathway, which on the one hand stimulates IL-1β secretion to alter hepatocyte lipid metabolism via IL-1β signaling, and on the other hand enhances direct lipid transfer from macrophages to hepatocytes, thereby synergistically exacerbating steatosis. Notably, treatment with Ire1α inhibitors (4μ8C and STF-083010) or IL-1β blockade (clinically approved anti-IL-1β antibodies) reverse established steatosis, inflammation, and fibrosis in preclinical mouse models. This work redefines the role of zinc in MASLD, shifting the paradigm from systemic deficiency to cell-specific sequestration. It reveals that zinc accumulation in macrophages exacerbates hepatocyte lipid accumulation through both fatty acid transflux and inflammation-driven metabolic reprogramming, uncovering novel therapeutic targets and a clinically actionable biomarker.
科研通智能强力驱动
Strongly Powered by AbleSci AI